The inflammation based index (IBI) predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
Delali Akosua Adjogatse
No relevant relationships to disclose
George Karamanakos
No relevant relationships to disclose
David James Pinato
No relevant relationships to disclose
Rohini Sharma
No relevant relationships to disclose